HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1.

Abstract
Niemann-Pick disease type C1 (NP-C1) is a rare lysosomal storage disorder resulting from mutations in an endolysosomal cholesterol transporter, NPC1. Despite typically presenting with pronounced neurological manifestations, NP-C1 also resembles long-term congenital immunodeficiencies that arise from impairment of cytotoxic T lymphocyte (CTL) effector function. CTLs kill their targets through exocytosis of the contents of lysosome-like secretory cytotoxic granules (CGs) that store and ultimately release the essential pore-forming protein perforin and proapoptotic serine proteases, granzymes, into the synapse formed between the CTL and target cell. We discovered that NPC1 deficiency increases CG lipid burden, impairs autophagic flux through stalled trafficking of the transcription factor EB (TFEB), and dramatically reduces CTL cytotoxicity. Using a variety of immunological and cell biological techniques, we found that the cytotoxic defect arises specifically from impaired perforin pore formation. We demonstrated defects of CTL function of varying severity in patients with NP-C1, with the greatest losses of function associated with the most florid and/or earliest disease presentations. Remarkably, perforin function and CTL cytotoxicity were restored in vitro by promoting lipid clearance with therapeutic 2-hydroxypropyl-β-cyclodextrin; however, restoration of autophagy through TFEB overexpression was ineffective. Overall, our study revealed that NPC1 deficiency has a deleterious impact on CTL (but not natural killer cell) cytotoxicity that, in the long term, may predispose patients with NP-C1 to atypical infections and impaired immune surveillance more generally.
AuthorsDaniela Castiblanco, Jesse A Rudd-Schmidt, Tahereh Noori, Vivien R Sutton, Ya Hui Hung, Thijs W H Flinsenberg, Adrian W Hodel, Neil D Young, Nicholas Smith, Drago Bratkovic, Heidi Peters, Mark Walterfang, Joseph A Trapani, Amelia J Brennan, Ilia Voskoboinik
JournalBlood (Blood) Vol. 139 Issue 12 Pg. 1833-1849 (03 24 2022) ISSN: 1528-0020 [Electronic] United States
PMID35081253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 by The American Society of Hematology.
Chemical References
  • Perforin
  • Cholesterol
  • Granzymes
Topics
  • Cholesterol (metabolism)
  • Granzymes
  • Humans
  • Niemann-Pick Disease, Type A
  • Niemann-Pick Disease, Type C (metabolism)
  • Perforin (genetics)
  • T-Lymphocytes, Cytotoxic (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: